The FBI has issued a warning about counterfeit versions of compounded weight loss drugs, which have been found to contain "unknown drugs, hig ...

Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...

A new study links semaglutide, the active ingredient in Ozempic and Wegovy, to a higher risk of hair loss, especially in ...

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...